Literature DB >> 17390222

Chlorzoxazone as a cause of acute liver failure requiring liver transplantation.

James Jackson1, Frank A Anania.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17390222     DOI： 10.1007/s10620-006-9677-0

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  11 in total

1.  [DIRECTED MYOTONOLYTIC THERAPY WITH PARAFLEX (CHLOROZOAXONE) IN ACCIDENT THERAPY].

Authors:  G BRUNNER
Journal:  Med Welt       Date:  1964-11-14

2.  Pharmacokinetics of chlorzoxazone in humans.

Authors:  R K Desiraju; N L Renzi; R K Nayak; K T Ng
Journal:  J Pharm Sci       Date:  1983-09       Impact factor: 3.534

Review 3.  The clinical importance of conventional and quantitative liver function tests in liver transplantation.

Authors:  E Tanaka; S Inomata; H Yasuhara
Journal:  J Clin Pharm Ther       Date:  2000-12       Impact factor: 2.512

4.  Effects of zoxazolamine and related centrally acting muscle relaxants on nigrostriatal dopaminergic neurons.

Authors:  R T Matthews; B A McMillen; S G Speciale; H Jarrah; P A Shore; M K Sanghera; P D Shepard; D C German
Journal:  Brain Res Bull       Date:  1984-05       Impact factor: 4.077

Review 5.  Chlorzoxazone hepatotoxic reactions. An analysis of 21 identified or presumed cases.

Authors:  B J Powers; E L Cattau; H J Zimmerman
Journal:  Arch Intern Med       Date:  1986-06

6.  Liver transplantation for acute liver failure from drug induced liver injury in the United States.

Authors:  Mark W Russo; Joseph A Galanko; Roshan Shrestha; Michael W Fried; Paul Watkins
Journal:  Liver Transpl       Date:  2004-08       Impact factor: 5.799

7.  Mechanism of induction of cytochrome P-450ac (P-450j) in chemically induced and spontaneously diabetic rats.

Authors:  Z G Dong; J Y Hong; Q A Ma; D C Li; J Bullock; F J Gonzalez; S S Park; H V Gelboin; C S Yang
Journal:  Arch Biochem Biophys       Date:  1988-05-15       Impact factor: 4.013

8.  Assessment of cytochrome P4502E1 induction in alcoholic patients by chlorzoxazone pharmacokinetics.

Authors:  C Girre; D Lucas; E Hispard; C Menez; S Dally; J F Menez
Journal:  Biochem Pharmacol       Date:  1994-04-29       Impact factor: 5.858

9.  The induction of a specific form of cytochrome P-450 (P-450j) by fasting.

Authors:  J Y Hong; J M Pan; F J Gonzalez; H V Gelboin; C S Yang
Journal:  Biochem Biophys Res Commun       Date:  1987-02-13       Impact factor: 3.575

10.  Effect of fasting and obesity in humans on the 6-hydroxylation of chlorzoxazone: a putative probe of CYP2E1 activity.

Authors:  D O'Shea; S N Davis; R B Kim; G R Wilkinson
Journal:  Clin Pharmacol Ther       Date:  1994-10       Impact factor: 6.875
View more
  1 in total

1.  Chlorzoxazone, an SK-type potassium channel activator used in humans, reduces excessive alcohol intake in rats.

Authors:  F Woodward Hopf; Jeffrey A Simms; Shao-Ju Chang; Taban Seif; Selena E Bartlett; Antonello Bonci
Journal:  Biol Psychiatry       Date:  2010-12-31       Impact factor: 13.382
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.